Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Korse

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
The International Journal of Biological Markers|June 15, 1999
TPA and CA 15.3 measurements for breast cancer monitoring in a routine settingJ M Bonfrer, C M Korse
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 25, 2000
Monitoring malignant melanoma with the S-100B tumour markerJ M Bonfrer, C M Korse
British Journal of Cancer|October 13, 2011
Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumoursC M Korse, M Muller, B G Taal
Anticancer Research|July 1, 1997
Serum S-100 has prognostic significance in malignant melanomaJ M Bonfrer, C M Korse, S P Israels
The International Journal of Biological Markers|April 19, 2005
Comparison of four different assays for determination of serum S-100BL H M Smit, C M Korse, J M G Bonfrer
Anticancer Research|July 1, 1997
Cyfra 21-1 and TPA as markers in malignant mesotheliomaJ M Bonfrer, J H Schouwink, C M Korse, et al.
British Journal of Cancer|July 2, 1998
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanomaJ M Bonfrer, C M Korse, O E Nieweg, et al.
Melanoma Research|February 6, 2003
Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanomaA P Hamberg, C M Korse, J M Bonfrer, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 1999
Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesotheliomaH Schouwink, C M Korse, J M Bonfrer, et al.
Climacteric : the Journal of the International Menopause Society|May 17, 2017
Impact of risk-reducing salpingo-oophorectomy in premenopausal womenR F M Vermeulen, M van Beurden, C M Korse, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
The International Journal of Biological Markers|June 15, 1999
TPA and CA 15.3 measurements for breast cancer monitoring in a routine settingJ M Bonfrer, C M Korse
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 25, 2000
Monitoring malignant melanoma with the S-100B tumour markerJ M Bonfrer, C M Korse
British Journal of Cancer|October 13, 2011
Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumoursC M Korse, M Muller, B G Taal
Anticancer Research|July 1, 1997
Serum S-100 has prognostic significance in malignant melanomaJ M Bonfrer, C M Korse, S P Israels
The International Journal of Biological Markers|April 19, 2005
Comparison of four different assays for determination of serum S-100BL H M Smit, C M Korse, J M G Bonfrer
Anticancer Research|July 1, 1997
Cyfra 21-1 and TPA as markers in malignant mesotheliomaJ M Bonfrer, J H Schouwink, C M Korse, et al.
British Journal of Cancer|July 2, 1998
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanomaJ M Bonfrer, C M Korse, O E Nieweg, et al.
Melanoma Research|February 6, 2003
Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanomaA P Hamberg, C M Korse, J M Bonfrer, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 1999
Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesotheliomaH Schouwink, C M Korse, J M Bonfrer, et al.
Climacteric : the Journal of the International Menopause Society|May 17, 2017
Impact of risk-reducing salpingo-oophorectomy in premenopausal womenR F M Vermeulen, M van Beurden, C M Korse, et al.
Pageof 4